Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 345

1.

A Method for Tracking Implementation Strategies: An Exemplar Implementing Measurement-Based Care in Community Behavioral Health Clinics.

Boyd MR, Powell BJ, Endicott D, Lewis CC.

Behav Ther. 2018 Jul;49(4):525-537. doi: 10.1016/j.beth.2017.11.012. Epub 2017 Dec 12.

PMID:
29937255
2.

Implementing measurement based care in community mental health: a description of tailored and standardized methods.

Lewis CC, Puspitasari A, Boyd MR, Scott K, Marriott BR, Hoffman M, Navarro E, Kassab H.

BMC Res Notes. 2018 Jan 27;11(1):76. doi: 10.1186/s13104-018-3193-0.

3.

The creation and validation of the Measure of Effective Attributes of Trainers (MEAT).

Boyd MR, Lewis CC, Scott K, Krendl A, Lyon AR.

Implement Sci. 2017 Jun 2;12(1):73. doi: 10.1186/s13012-017-0603-y.

4.

Will peripherally restricted kappa-opioid receptor agonists (pKORAs) relieve pain with less opioid adverse effects and abuse potential?

Albert-Vartanian A, Boyd MR, Hall AL, Morgado SJ, Nguyen E, Nguyen VP, Patel SP, Russo LJ, Shao AJ, Raffa RB.

J Clin Pharm Ther. 2016 Aug;41(4):371-82. doi: 10.1111/jcpt.12404. Epub 2016 Jun 1. Review.

PMID:
27245498
5.

Capabilities and Characteristics of Digital Measurement Feedback Systems: Results from a Comprehensive Review.

Lyon AR, Lewis CC, Boyd MR, Hendrix E, Liu F.

Adm Policy Ment Health. 2016 May;43(3):441-66. doi: 10.1007/s10488-016-0719-4. Review.

6.

Using Debates to Teach Evidence-Based Practice in Large Online Courses.

Boyd MR, Baliko B, Polyakova-Norwood V.

J Nurs Educ. 2015 Oct;54(10):578-82. doi: 10.3928/01484834-20150916-06.

PMID:
26431518
7.

Redesigning a graduate research course for evidence-based competencies.

Boyd MR, Baliko B, Herman J, Polyakova-Norwood V.

J Nurs Educ. 2012 Nov;51(11):652-5. doi: 10.3928/01484834-20120927-01. Epub 2012 Sep 27.

PMID:
23013065
8.

Predictors of alcohol and drug problems in rural African American women.

Boyd MR, Berger KC, Baliko B, Tavakoli A.

Issues Ment Health Nurs. 2009 Jun;30(6):383-91. doi: 10.1080/01612840802509478.

PMID:
19499439
9.

Influenza A (H1N1) virus resistance to cyanovirin-N arises naturally during adaptation to mice and by passage in cell culture in the presence of the inhibitor.

Smee DF, Wandersee MK, Checketts MB, O'Keefe BR, Saucedo C, Boyd MR, Mishin VP, Gubareva LV.

Antivir Chem Chemother. 2007;18(6):317-27.

PMID:
18320936
10.

Candidaspongiolides, distinctive analogues of tedanolide from sponges of the genus Candidaspongia.

Meragelman TL, Willis RH, Woldemichael GM, Heaton A, Murphy PT, Snader KM, Newman DJ, van Soest R, Boyd MR, Cardellina JH 2nd, McKee TC.

J Nat Prod. 2007 Jul;70(7):1133-8. Epub 2007 Jun 12.

11.

Stress, coping, and alcohol expectancies in rural African-American women.

Boyd MR, Baliko B, Cox MF, Tavakoli A.

Arch Psychiatr Nurs. 2007 Apr;21(2):70-9.

PMID:
17397688
12.

Bioengineering lactic acid bacteria to secrete the HIV-1 virucide cyanovirin.

Pusch O, Boden D, Hannify S, Lee F, Tucker LD, Boyd MR, Wells JM, Ramratnam B.

J Acquir Immune Defic Syndr. 2005 Dec 15;40(5):512-20.

PMID:
16284525
13.

Antitumor activity and distribution of pyrroloiminoquinones in the sponge genus Zyzzya.

Dijoux MG, Schnabel PC, Hallock YF, Boswell JL, Johnson TR, Wilson JA, Ireland CM, van Soest R, Boyd MR, Barrows LR, Cardellina JH 2nd.

Bioorg Med Chem. 2005 Nov 1;13(21):6035-44.

PMID:
16009557
14.

Disruption of left-right reciprocal coupling in the spinal cord of larval lamprey abolishes brain-initiated locomotor activity.

Jackson AW, Horinek DF, Boyd MR, McClellan AD.

J Neurophysiol. 2005 Sep;94(3):2031-44. Epub 2005 Jul 6. Erratum in: J Neurophysiol. 2005 Nov;94(5):3658.

15.

Sleep disturbance and depression as barriers to adherence.

Phillips KD, Moneyham L, Murdaugh C, Boyd MR, Tavakoli A, Jackson K, Vyavaharkar M.

Clin Nurs Res. 2005 Aug;14(3):273-93.

PMID:
15995155
16.

A peer-based substance abuse intervention for HIV+ rural women: a pilot study.

Boyd MR, Moneyham L, Murdaugh C, Phillips KD, Tavakoli A, Jackwon K, Jackson N, Vyavaharkar M.

Arch Psychiatr Nurs. 2005 Feb;19(1):10-7.

PMID:
15765367
17.

Isolation and characterization of griffithsin, a novel HIV-inactivating protein, from the red alga Griffithsia sp.

Mori T, O'Keefe BR, Sowder RC 2nd, Bringans S, Gardella R, Berg S, Cochran P, Turpin JA, Buckheit RW Jr, McMahon JB, Boyd MR.

J Biol Chem. 2005 Mar 11;280(10):9345-53. Epub 2004 Dec 21.

18.

Development of a fluorescent microplate assay for determining cyanovirin-N levels in plasma.

Bringans SD, O'Keefe BR, Bray M, Whitehouse CA, Boyd MR.

Anal Bioanal Chem. 2004 Sep;380(2):269-74. Epub 2004 Aug 27.

PMID:
15338095
19.

Neamphamide A, a new HIV-inhibitory depsipeptide from the Papua New Guinea marine sponge Neamphius huxleyi.

Oku N, Gustafson KR, Cartner LK, Wilson JA, Shigematsu N, Hess S, Pannell LK, Boyd MR, McMahon JB.

J Nat Prod. 2004 Aug;67(8):1407-11.

PMID:
15332865
20.

Cytotoxic alkaloids from the marine sponge Thorectandra sp.

Charan RD, McKee TC, Boyd MR.

Nat Prod Res. 2004 Jun;18(3):225-9.

PMID:
15143832
21.

Gymnangiamide, a cytotoxic pentapeptide from the marine hydroid Gymnangium regae.

Milanowski DJ, Gustafson KR, Rashid MA, Pannell LK, McMahon JB, Boyd MR.

J Org Chem. 2004 Apr 30;69(9):3036-42.

PMID:
15104441
22.

A frameshift mutation and alternate splicing in human brain generate a functional form of the pseudogene cytochrome P4502D7 that demethylates codeine to morphine.

Pai HV, Kommaddi RP, Chinta SJ, Mori T, Boyd MR, Ravindranath V.

J Biol Chem. 2004 Jun 25;279(26):27383-9. Epub 2004 Mar 29.

23.

Cyclonellin, a new cyclic octapeptide from the marine sponge Axinella carteri.

Milanowski DJ, Rashid MA, Gustafson KR, O'Keefe BR, Nawrocki JP, Pannell LK, Boyd MR.

J Nat Prod. 2004 Mar;67(3):441-4.

PMID:
15043426
24.

Cyanovirin-N inhibits AIDS virus infections in vaginal transmission models.

Tsai CC, Emau P, Jiang Y, Agy MB, Shattock RJ, Schmidt A, Morton WR, Gustafson KR, Boyd MR.

AIDS Res Hum Retroviruses. 2004 Jan;20(1):11-8.

PMID:
15000694
25.
26.

Alcohol and other drug disorders, comorbidity, and violence: comparison of rural African American and Caucasian women.

Boyd MR, Phillips K, Dorsey CJ.

Arch Psychiatr Nurs. 2003 Dec;17(6):249-58.

PMID:
14685949
27.

Identification of a new chondropsin class of antitumor compound that selectively inhibits V-ATPases.

Bowman EJ, Gustafson KR, Bowman BJ, Boyd MR.

J Biol Chem. 2003 Nov 7;278(45):44147-52. Epub 2003 Aug 27.

28.

Cyanovirin-N gel as a topical microbicide prevents rectal transmission of SHIV89.6P in macaques.

Tsai CC, Emau P, Jiang Y, Tian B, Morton WR, Gustafson KR, Boyd MR.

AIDS Res Hum Retroviruses. 2003 Jul;19(7):535-41.

PMID:
12921090
29.

Potent anti-influenza activity of cyanovirin-N and interactions with viral hemagglutinin.

O'Keefe BR, Smee DF, Turpin JA, Saucedo CJ, Gustafson KR, Mori T, Blakeslee D, Buckheit R, Boyd MR.

Antimicrob Agents Chemother. 2003 Aug;47(8):2518-25.

30.

Cyanovirin-N binds to the viral surface glycoprotein, GP1,2 and inhibits infectivity of Ebola virus.

Barrientos LG, O'Keefe BR, Bray M, Sanchez A, Gronenborn AM, Boyd MR.

Antiviral Res. 2003 Mar;58(1):47-56.

PMID:
12719006
31.

Vulnerability to alcohol and other drug disorders in rural women.

Boyd MR.

Arch Psychiatr Nurs. 2003 Feb;17(1):33-41.

PMID:
12642886
32.

A potent novel anti-HIV protein from the cultured cyanobacterium Scytonema varium.

Bokesch HR, O'Keefe BR, McKee TC, Pannell LK, Patterson GM, Gardella RS, Sowder RC 2nd, Turpin J, Watson K, Buckheit RW Jr, Boyd MR.

Biochemistry. 2003 Mar 11;42(9):2578-84.

PMID:
12614152
33.

Stress and coping in rural women with alcohol and other drug disorders.

Boyd MR, Bland A, Herman J, Mestler L, Murr L, Potts L.

Arch Psychiatr Nurs. 2002 Dec;16(6):254-62.

PMID:
12567373
34.

Changes in locomotor activity parameters with variations in cycle time in larval lamprey.

Boyd MR, McClellan AD.

J Exp Biol. 2002 Dec;205(Pt 23):3707-16.

35.

Multisite and multivalent binding between cyanovirin-N and branched oligomannosides: calorimetric and NMR characterization.

Shenoy SR, Barrientos LG, Ratner DM, O'Keefe BR, Seeberger PH, Gronenborn AM, Boyd MR.

Chem Biol. 2002 Oct;9(10):1109-18.

36.

Functional homologs of cyanovirin-N amenable to mass production in prokaryotic and eukaryotic hosts.

Mori T, Barrientos LG, Han Z, Gronenborn AM, Turpin JA, Boyd MR.

Protein Expr Purif. 2002 Oct;26(1):42-9.

PMID:
12356469
37.

Thioltransferase (glutaredoxin) mediates recovery of motor neurons from excitotoxic mitochondrial injury.

Kenchappa RS, Diwakar L, Boyd MR, Ravindranath V.

J Neurosci. 2002 Oct 1;22(19):8402-10.

38.

New dimeric macrolide glycosides from the marine sponge Myriastra clavosa.

Erickson KL, Gustafson KR, Pannell LK, Beutler JA, Boyd MR.

J Nat Prod. 2002 Sep;65(9):1303-6.

PMID:
12350152
39.

Isolation and structure of pedilstatin from a republic of maldives Pedilanthus sp.

Pettit GR, Ducki S, Tan R, Gardella RS, McMahon JB, Boyd MR, Pettit GR 3rd, Blumberg PM, Lewin NE, Doubek DL, Tackett LP, Williams MD.

J Nat Prod. 2002 Sep;65(9):1262-5.

PMID:
12350143
40.

Unusual sulfamate indoles and a novel indolo[3,2-a]carbazole from Ancorina sp.

Meragelman KM, West LM, Northcote PT, Pannell LK, McKee TC, Boyd MR.

J Org Chem. 2002 Sep 20;67(19):6671-7.

PMID:
12227796
41.
42.

The microbicide cyanovirin-N expressed on the surface of commensal bacterium Streptococcus gordonii captures HIV-1.

Giomarelli B, Provvedi R, Meacci F, Maggi T, Medaglini D, Pozzi G, Mori T, McMahon JB, Gardella R, Boyd MR.

AIDS. 2002 Jul 5;16(10):1351-6.

PMID:
12131211
43.

Structures of the complexes of a potent anti-HIV protein cyanovirin-N and high mannose oligosaccharides.

Botos I, O'Keefe BR, Shenoy SR, Cartner LK, Ratner DM, Seeberger PH, Boyd MR, Wlodawer A.

J Biol Chem. 2002 Sep 13;277(37):34336-42. Epub 2002 Jul 10.

44.

Constitutive expression and localization of the major drug metabolizing enzyme, cytochrome P4502D in human brain.

Chinta SJ, Pai HV, Upadhya SC, Boyd MR, Ravindranath V.

Brain Res Mol Brain Res. 2002 Jun 30;103(1-2):49-61.

PMID:
12106691
45.

Domain-swapped structure of a mutant of cyanovirin-N.

Botos I, Mori T, Cartner LK, Boyd MR, Wlodawer A.

Biochem Biophys Res Commun. 2002 May 31;294(1):184-90.

PMID:
12054761
46.

Antineoplastic agents 460. Synthesis of combretastatin A-2 prodrugs.

Pettit GR, Moser BR, Boyd MR, Schmidt JM, Pettit RK, Chapuis JC.

Anticancer Drug Des. 2001 Aug-Oct;16(4-5):185-93.

PMID:
12049477
47.

The domain-swapped dimer of cyanovirin-N is in a metastable folded state: reconciliation of X-ray and NMR structures.

Barrientos LG, Louis JM, Botos I, Mori T, Han Z, O'Keefe BR, Boyd MR, Wlodawer A, Gronenborn AM.

Structure. 2002 May;10(5):673-86.

48.

High throughput screening for cyanovirin-N mimetics binding to HIV-1 gp41.

Beutler JA, McMahon JB, Johnson TR, O'Keefe BR, Buzzell RA, Robbins D, Gardella R, Wilson J, Boyd MR.

J Biomol Screen. 2002 Apr;7(2):105-10.

PMID:
12006108
49.

Thorectandrols C, D, and E, new sesterterpenes from the marine sponge Thorectandra sp.

Charan RD, McKee TC, Boyd MR.

J Nat Prod. 2002 Apr;65(4):492-5.

PMID:
11975486
50.

Discovery of a stable dimeric mutant of cyanovirin-N (CV-N) from a T7 phage-displayed CV-N mutant library.

Han Z, Xiong C, Mori T, Boyd MR.

Biochem Biophys Res Commun. 2002 Apr 12;292(4):1036-43.

PMID:
11944919

Supplemental Content

Support Center